Erlocip 150 mg (Erlotinib)
| Active Ingredient | Erlotinib |
|---|---|
| Dosage Form | Tablet |
| Available Strength | 150mg |
| Manufacturer: | Cipla Limited |
| Packaging | 30 tablets in 1 bottle |
| Therapeutic use | Non-small cell lung cancer, Pancreatic cancer |
| Pack Insert/Leaflet | Yes |
| Production Capacity | 1 Million Bottle's/Month |
Reviews
There are no reviews yet.